Company intelligence / Profile preview

China Pioneer Pharma

Shanghai, Shanghai, Chinapioneer-pharma.com ↗

Ownership: Private
Employees: ~335
Development stage: Other

Overview

China Pioneer Pharma markets, sells, and distributes mostly prescription pharmaceutical products and branded medical devices in China; products such as pidotimod (Polimod), cardiovascular, immunology, gynecology, gastroenterology, and wound care products are actively commercialized. In recent years, the company has begun transforming into an integrated pharmaceutical company with manufacturing and R&D capabilities.

Therapeutic areas: ImmunologyOphthalmologyInfectious DiseasesGastroenterologyDermatologyCardiovascularOtherNeurologyWomen's Health
Modalities: Small moleculeMedical device
Industry: Biotech

Partnerships

NovaBay Pharmaceuticals (US, products: CelleRx, i-Lid Cleanser, NeutroPhase)

Beyond the preview

Go deeper on China Pioneer Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Pioneer Pharma.